FibroGen Inc
LSE:0IL8
FibroGen Inc
LSE:0IL8
Price:
7.28
USD
-0.24%
Market Cap:
$29.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
FibroGen Inc
LSE:0IL8
|
US |
|
S
|
SOL SpA
LSE:0NJP
|
IT |
|
Nebius Group NV
NASDAQ:NBIS
|
NL |
|
TechTarget Inc
NASDAQ:TTGT
|
US |
|
GAIL (India) Ltd
NSE:GAIL
|
IN |
|
O
|
Onyx Gold Corp
XTSX:ONYX
|
CA |
|
V
|
Volkswagen AG
F:VOW
|
DE |
Wall St Price Targets
0IL8 Price Targets Summary
FibroGen Inc
FibroGen Inc
Wall Street analysts forecast 0IL8 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0IL8 is 44.39 USD with a low forecast of 43.95 USD and a high forecast of 45.69 USD.
Lowest Forecast
Price Target
43.95
USD
504% Upside
Average Forecast
Price Target
44.39
USD
510% Upside
Highest Forecast
Price Target
45.69
USD
528% Upside
FibroGen Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0IL8's stock price target?
Price Target
44.39
USD
44.39
USD
According to Wall Street analysts, the average 1-year price target for 0IL8 is 44.39 USD with a low forecast of 43.95 USD and a high forecast of 45.69 USD.
What is the Revenue forecast for FibroGen Inc?
Projected CAGR
-32%
-32%
Over the last 11 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is -32%.
